ARTICLE | Clinical News
4SC gains on IBD data
November 5, 2010 12:26 AM UTC
4SC AG (Xetra:VSC) gained EUR 0.41 (15%) to EUR 3.18 on Thursday after reporting that once-daily oral vidofludimus for 12 weeks met the primary endpoint of significantly increasing response rate compa...